全文获取类型
收费全文 | 2118篇 |
免费 | 130篇 |
国内免费 | 25篇 |
专业分类
耳鼻咽喉 | 21篇 |
儿科学 | 21篇 |
妇产科学 | 36篇 |
基础医学 | 236篇 |
口腔科学 | 54篇 |
临床医学 | 175篇 |
内科学 | 697篇 |
皮肤病学 | 15篇 |
神经病学 | 115篇 |
特种医学 | 57篇 |
外科学 | 450篇 |
综合类 | 6篇 |
预防医学 | 72篇 |
眼科学 | 16篇 |
药学 | 114篇 |
中国医学 | 2篇 |
肿瘤学 | 186篇 |
出版年
2024年 | 5篇 |
2023年 | 34篇 |
2022年 | 73篇 |
2021年 | 107篇 |
2020年 | 47篇 |
2019年 | 75篇 |
2018年 | 73篇 |
2017年 | 43篇 |
2016年 | 68篇 |
2015年 | 70篇 |
2014年 | 90篇 |
2013年 | 83篇 |
2012年 | 153篇 |
2011年 | 134篇 |
2010年 | 88篇 |
2009年 | 60篇 |
2008年 | 127篇 |
2007年 | 154篇 |
2006年 | 120篇 |
2005年 | 125篇 |
2004年 | 117篇 |
2003年 | 80篇 |
2002年 | 92篇 |
2001年 | 25篇 |
2000年 | 16篇 |
1999年 | 29篇 |
1998年 | 15篇 |
1997年 | 16篇 |
1996年 | 13篇 |
1995年 | 10篇 |
1994年 | 9篇 |
1993年 | 7篇 |
1992年 | 9篇 |
1991年 | 18篇 |
1990年 | 9篇 |
1989年 | 9篇 |
1988年 | 10篇 |
1987年 | 5篇 |
1986年 | 4篇 |
1985年 | 6篇 |
1982年 | 3篇 |
1981年 | 5篇 |
1980年 | 3篇 |
1974年 | 2篇 |
1973年 | 3篇 |
1972年 | 2篇 |
1971年 | 4篇 |
1970年 | 7篇 |
1969年 | 6篇 |
1968年 | 2篇 |
排序方式: 共有2273条查询结果,搜索用时 15 毫秒
51.
52.
Yuki Nakamura Fumiaki Shikata Masahiro Ryugo Toru Okamura Takumi Yasugi Hironori Izutani 《Surgery today》2014,44(12):2378-2381
Hereditary hemorrhagic telangiectasia (HHT) is caused by an autosomal dominant gene and characterized by multiple arteriovenous malformations in several organs, leading to bleeding or shunting. These patients often suffer severe infections and heart failure, which should be managed in the perioperative period, when open heart surgery is indicated. We report a case of successful aortic root replacement for active prosthetic valve endocarditis and ventricular septal perforation in a patient with HHT, who had severe heart failure. 相似文献
53.
Sae Murakami Tetsuo Ajiki Kimihiko Ueno Hidehiro Sawa Shinobu Tsuchida Izuru Otsubo Yuko Yoshida Kenta Shinozaki Taro Okazaki Ippei Matsumoto Takumi Fukumoto Yonson Ku 《Surgery today》2014,44(7):1350-1354
A 25-year-old woman was referred to our hospital with persistent upper abdominal pain. Preoperative imaging studies revealed a hilar bile duct stricture with portal venous encasement, and the patient underwent curative resection involving extended left hepatectomy and segmental portal vein resection. The pathological findings demonstrated a well-differentiated tubular adenocarcinoma of the bile duct with regional lymph node metastasis (stage IIIB according to the UICC TNM classification), as well as the overexpression of p53 proteins and the K-ras gene mutation in tumor cells. The patient has shown no evidence of recurrence in the 10 months since the operation. Although there are several reports of relatively young adults with cholangiocarcinoma, the majority of such patients demonstrate either an anomalous arrangement of the pancreaticobiliary duct system or primary sclerosing cholangitis. The absence of any morphological abnormalities in this patient’s biliary system implicates de novo carcinogenesis as the most likely cause of the cholangiocarcinoma. 相似文献
54.
Takumi Fukumoto MD Masahiro Tominaga MD Masahiro Kido MD Atsushi Takebe MD Motofumi Tanaka MD Kaori Kuramitsu MD Ippei Matsumoto MD Tetsuo Ajiki MD Yonson Ku MD 《Annals of surgical oncology》2014,21(3):971-978
Background
Sorafenib is currently recommended as first-line therapy for patients with intermediate or advanced hepatocellular carcinoma (HCC) per Barcelona Clinic Liver Cancer staging. However, the median overall survival (OS) with sorafenib in these patients is 10.7 months with an overall response rate of 2 %. We retrospectively investigated the long-term outcomes and prognostic factors with reductive hepatectomy and sequential percutaneous isolated hepatic perfusion (PIHP) for refractory intermediate or advanced HCC.Methods
A total of 68 patients who had intermediate or advanced stage HCC without extrahepatic metastases were scheduled for reductive hepatectomy plus PIHP. All patients underwent reductive hepatectomy and PIHP with mitomycin C 20–40 mg/m2 and/or doxorubicin 60–120 mg/m2 1–3 months after surgery (mean, 1.51 times/patient).Results
The objective response rate of PIHP was 70.6 % (complete plus partial response). The median OS of all 68 patients was 25 months, and the 5-year OS rate was 27.6 %. Univariate and multivariate analyses indicated that tumor response to PIHP and normalization of serum des-γ-carboxy prothrombin concentrations after PIHP were independent prognostic factors for OS.Conclusions
The median OS of the study population treated by reductive hepatectomy and sequential PIHP was 25 months. This treatment strategy can offer a possible curative treatment to patients with refractory intermediate and advanced HCC. 相似文献55.
Kenzo Uchida Hideaki Nakajima Naoto Takeura Takafumi Yayama Alexander Rodriguez Guerrero Ai Yoshida Takumi Sakamoto Kazuya Honjoh Hisatoshi Baba 《The spine journal》2014,14(8):1601-1610
Background contextSignal intensity on preoperative cervical magnetic resonance imaging (MRI) of the spinal cord has been shown to be a potential predictor of outcome of surgery for cervical compressive myelopathy. However, the prognostic value of such signal remains controversial. One reason for the controversy is the lack of proper quantitative methods to assess MRI signal intensity.PurposeTo quantify signal intensity and to correlate intramedullary signal changes on MRI T1- and T2-weighted images (WIs) with clinical outcome and prognosis.Study designRetrospective case study.Patient samplePatients (n=148; cervical spondylotic myelopathy, n=102 and ossified posterior longitudinal ligament, n=46) who underwent surgery for cervical compressive myelopathy and had high signal intensity change on sagittal T2-WI MRI before surgery between 2006 and 2010.Outcome measureNeurologic assessment was conducted with the Japanese Orthopedic Association (JOA) scoring system for cervical myelopathy. The rate of neurologic improvement was calculated with the use of preoperative and postoperative JOA scores.MethodsQuantitative analysis of MRI signal on both T1- and T2-WIs via use of the signal intensity ratio (SIR; signal intensity of lesion relative to that at C7-T1 disc level) was performed. Correlations between SIR on T1- and T2-WIs and preoperative JOA score, JOA improvement rate, disease duration, and MRI morphologic classification (cystic or diffuse type) were analyzed. Multivariate regression analysis for JOA improvement rate was also analyzed. In a substudy, 25 patients underwent follow-up MRI starting from 6 months after surgery to analyze the relationship between changes in SIR on follow-up MRI and clinical outcome.ResultsSIR on T1-WIs, but not SIR on T2-WIs, correlated with postoperative neurologic improvement. The disease duration correlated negatively with SIR on T1-WIs and JOA improvement rate but not with SIR on T2-WIs. SIR on T2-WIs of “cystic type” was significantly greater than of “diffuse type,” but SIR on T1-WI and JOA improvement rate were not different in the two types. Stepwise multivariate regression analysis indicated that SIR on T1-WIs and long disease duration were significant predictors of postoperative neurologic outcome. SIR on follow-up T1-WI and changes in SIR on T1-WI after surgery correlated positively with postoperative improvement rate. SIR on follow-up T2-WI and changes on T2-WI correlated negatively with postoperative neurologic improvement.ConclusionsOur results suggest that low intensity signal on preoperative T1-WIs but not T2-WIs correlated with poor postoperative neurologic outcome. Furthermore, decreased signal intensity on postoperative T1-WIs and increased signal intensity on postoperative T2-WIs are predictors of poor neurologic outcome. 相似文献
56.
57.
58.
59.
Akihiro Nakajima MD Makoto Araki MD PhD Osamu Kurihara MD PhD Yoshiyasu Minami MD PhD Tsunenari Soeda MD PhD Taishi Yonetsu MD Filippo Crea MD FACC Masamichi Takano MD PhD Takumi Higuma MD PhD Tsunekazu Kakuta MD PhD Tom Adriaenssens MD PhD Hang Lee PhD Sunao Nakamura MD PhD FACC Ik-Kyung Jang MD PhD FACC 《Catheterization and cardiovascular interventions》2021,97(4):634-645
60.
Takumi Sumimoto Takaaki Ochi Taketoshi Ito Tadafumi Joh Shinjiro Muneta Kunio Hiwada 《Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy》1997,11(1):27-32
The aim of this study was to compare the effects of a calcium antagonist, nicardipine SR, with an angiotensin-converting enzyme (ACE) inhibitor, alacepril, on the regression of left ventricular hypertrophy (LVH) and function. Twenty patients with LVH, aged 42–73 years, were treated with nicardipine SR or alacepril. Ten patients were treated with nicardipine SR (40–80 mg) for 21 months, and the other 10 patients were treated with alacepril (25–100 mg) for 18 months. All patients underwent echocardiography to assess left ventricular structure and function before and after the treatment. After nicardipine SR or alacepril treatment, blood pressure was decreased significantly from 176.0 ± 13.9/97.0 ± 5.3 mmHg to 140.0 ± 14.0/77.4 ± 7.2 mmHg and from 168.2 ± 22.3/99.0 ± 5.5 mmHg to 138.4 ± 12.5/85.2 ± 9.7 mmHg, respectively (both p < 0.01), whereas heart rate did not change (73.8 ± 14.6 beats/min vs. 69.9 ± 13.5 beats/min and 71.6 ± 9.7 vs. 65.8 ± 8.1 beats/min, respectively). The left ventricular mass index decreased significantly from 133.2 ± 11.7 g/m2 to 114.4 ± 15.7 g/m2 with nicardipine SR and from 137.1 ± 14.8 g/m2 to 99.3 ± 23.0 g/m2 with alacepril (both p < 0.01). The fractional shortening, peak shortening rate, and peak lengthening rate all improved significantly after each treatment. The end-systolic wall stress/left ventricular end-systolic volume index, as an index of left ventricular contractility, was decreased significantly after treatment with nicardipine SR but was not changed after treatment with alacepril. In conclusion, both nicardipine SR and alacepril similarly reduced LVH and improved left ventricular systolic and diastolic function. However, alacepril did not alter left ventricular contractility, whereas nicardi-pine SR decreased left ventricular contractility. 相似文献